Summary:
The study is for individuals with Alzheimer's Disease or mild cognitive impairment due to Alzheimer's Disease. The study lasts 18 months with an optional 24 month long-term extension. The study includes the completion of MRI and PET scan imaging.
Qualified Participants Must:
Be between 50 and 85 years of age
Have experienced memory decline for at least one year
Suspect memory decline may be due to Alzheimer's Disease or have been diagnosed with Alzheimer's Disease
Qualified Participants May Receive:
Study-related medical care and study medication; reimbursement for time and travel will be provided